Equity Incentive Plan (Tables)

12 Months Ended

Mar. 31, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of Assumptions Utilized to Estimate the Fair Value of Stock Options Granted

The assumptions utilized to estimate the fair value of stock options granted are presented in the following table:

	Year Ended
	March 31,
	2021	2020
Risk free interest rate	0.174% - 0.527%	0.304% - 2.38%
Expected volatility	88.02% - 101.67%	71.65% - 78.95%
Expected term	2.8 - 6.1 years	2.5 - 6 years
Dividend yield	0.0%	0.0%

Schedule of Stock Options

The following is a summary of the activity of the Company’s stock options under the 2015 Plan and 2016 Director Plan as of March 31, 2021:

	Number of Options			Weighted Average Exercise Price
Outstanding at March 31, 2020		11,815,982		$	3.43
Granted		5,568,000			1.24
Exercised		(2,028,203	)		2.64
Cancelled/Forfeited		(2,767,711	)		1.93
Outstanding at March 31, 2021		12,588,068			2.92
Options exercisable at March 31, 2021		8,232,897		$	3.77

Schedule of Stock Option by Exercise Price Range

	Stock Options Outstanding								Stock Options Vested
Range of Exercise Price	Number Outstanding at March 31, 2021		Weighted Average Exercise Price		Weighted Average Remaining Life (Years)		Aggregate Intrinsic Value		Number Vested at March 31, 2021		Weighted Average Exercise Price		Weighted Average Remaining Life (Years)		Aggregate Intrinsic Value
$0.95 - $8.75		12,588,068	$	2.92		7.33	$	3,295,837		8,232,897	$	3.77		6.46	$	1,002,042

Schedule of Non-vested Options

	Options			Weighted Average Grant Date Fair Value Per Share
Non-vested options at March 31, 2020		3,591,507		$	1.36
Granted		5,568,000			0.89
Vested		(2,920,332	)		1.27
Cancelled/Forfeited		(1,884,004	)		1.13
Non-vested options at March 31, 2021		4,355,171		$	0.91